Stock 4111 CHI SHENG PHARMA & BIOTECH CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Financials Chi Sheng Pharma & Biotech Co., Ltd

Equities

4111

TW0004111000

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 23:00:00 27/05/2024 BST 		5-day change 1st Jan Change
29.3 TWD -0.68% Intraday chart for Chi Sheng Pharma & Biotech Co., Ltd -8.58% +9.94%
03-14 Chi Sheng Pharma & Biotech Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Chi Sheng Pharma & Biotech Co., Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,368 1,416 1,365 1,316 1,544 1,519
Enterprise Value (EV) 1 1,177 1,156 1,041 1,208 1,216 1,260
P/E ratio 32.4 x 19.6 x 23.3 x 16.4 x 10.1 x 22.2 x
Yield 2.5% 4.02% 4.18% 4.33% 4.43% 3.75%
Capitalization / Revenue 1.41 x 1.38 x 1.39 x 1.26 x 1.35 x 1.43 x
EV / Revenue 1.22 x 1.13 x 1.06 x 1.16 x 1.06 x 1.19 x
EV / EBITDA 9.96 x 7.09 x 6.83 x 7.38 x 5.55 x 10.7 x
EV / FCF 110 x 10.5 x 9.38 x -7.64 x 11.5 x -24.9 x
FCF Yield 0.91% 9.53% 10.7% -13.1% 8.69% -4.02%
Price to Book 1.31 x 1.32 x 1.27 x 1.2 x 1.26 x 1.25 x
Nbr of stocks (in thousands) 56,983 56,983 56,983 56,983 56,983 56,983
Reference price 2 24.00 24.85 23.95 23.10 27.10 26.65
Announcement Date 01/04/19 20/03/20 30/03/21 28/03/22 24/03/23 14/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 967.4 1,023 979.4 1,042 1,143 1,061
EBITDA 1 118.2 163 152.5 163.6 219.2 117.6
EBIT 1 42.64 87.26 75.55 91.74 153.8 61.21
Operating Margin 4.41% 8.53% 7.71% 8.81% 13.46% 5.77%
Earnings before Tax (EBT) 1 60.06 97.26 81.42 104.8 162.3 87.33
Net income 1 42.25 72.45 59.14 80.75 154 68.67
Net margin 4.37% 7.08% 6.04% 7.75% 13.47% 6.47%
EPS 2 0.7400 1.270 1.030 1.410 2.689 1.200
Free Cash Flow 1 10.68 110.2 111.1 -158.1 105.7 -50.71
FCF margin 1.1% 10.77% 11.34% -15.17% 9.24% -4.78%
FCF Conversion (EBITDA) 9.04% 67.61% 72.84% - 48.2% -
FCF Conversion (Net income) 25.29% 152.11% 187.77% - 68.61% -
Dividend per Share 2 0.6000 1.000 1.000 1.000 1.200 1.000
Announcement Date 01/04/19 20/03/20 30/03/21 28/03/22 24/03/23 14/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4
Net sales 1 - 289.3
EBITDA - -
EBIT 1 - 66.84
Operating Margin - 23.1%
Earnings before Tax (EBT) 1 - 61.44
Net income 1 47.09 54.39
Net margin - 18.8%
EPS 2 0.8200 0.9500
Dividend per Share - -
Announcement Date 10/11/22 24/03/23
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 191 260 323 108 328 258
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 10.7 110 111 -158 106 -50.7
ROE (net income / shareholders' equity) 4.03% 6.84% 5.51% 7.42% 15.4% 5.63%
ROA (Net income/ Total Assets) 1.79% 3.61% 3.14% 3.64% 5.56% 2.15%
Assets 1 2,367 2,009 1,884 2,216 2,771 3,201
Book Value Per Share 2 18.30 18.80 18.90 19.30 21.40 21.40
Cash Flow per Share 2 3.970 4.830 5.890 4.430 8.010 6.690
Capex 1 75.4 36.5 22 265 105 101
Capex / Sales 7.79% 3.57% 2.25% 25.42% 9.21% 9.57%
Announcement Date 01/04/19 20/03/20 30/03/21 28/03/22 24/03/23 14/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

1st Jan change Capi.
CHI SHENG PHARMA & BIOTECH CO., LTD Stock Chi Sheng Pharma & Biotech Co., Ltd
+9.94% 51.85M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+18.54% 42.25B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+15.37% 21.27B
SANDOZ GROUP AG Stock Sandoz Group AG
+19.59% 15.23B
CIPLA LIMITED Stock Cipla Limited
+20.08% 14.36B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+52.23% 12.74B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-12.40% 6.61B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.28% 5.66B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4111 Stock
  4. Financials Chi Sheng Pharma & Biotech Co., Ltd